Annual EBIT
-$143.09 M
-$88.97 M-164.38%
December 31, 2024
Summary
- As of March 4, 2025, MLTX annual earnings before interest & taxes is -$143.09 million, with the most recent change of -$88.97 million (-164.38%) on December 31, 2024.
- MLTX annual EBIT is now -164.38% below its all-time high of -$54.12 million, reached on December 31, 2023.
Performance
MLTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$49.58 M
-$6.47 M-15.00%
December 31, 2024
Summary
- As of March 4, 2025, MLTX quarterly earnings before interest & taxes is -$49.58 million, with the most recent change of -$6.47 million (-15.00%) on December 31, 2024.
- Over the past year, MLTX quarterly EBIT has dropped by -$6.47 million (-15.00%).
- MLTX quarterly EBIT is now -691.11% below its all-time high of -$6.27 million, reached on September 30, 2021.
Performance
MLTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$143.09 M
-$34.55 M-31.83%
December 31, 2024
Summary
- As of March 4, 2025, MLTX TTM earnings before interest & taxes is -$143.09 million, with the most recent change of -$34.55 million (-31.83%) on December 31, 2024.
- Over the past year, MLTX TTM EBIT has dropped by -$34.55 million (-31.83%).
- MLTX TTM EBIT is now -337.83% below its all-time high of -$32.68 million, reached on June 30, 2021.
Performance
MLTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MLTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -164.4% | -15.0% | -31.8% |
| 3 y3 years | - | -283.4% | -130.6% |
| 5 y5 years | - | -283.4% | -130.6% |
MLTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -164.4% | at low | -283.4% | at low | -259.0% | at low |
| 5 y | 5-year | -164.4% | at low | -691.1% | at low | -337.8% | at low |
| alltime | all time | -164.4% | at low | -691.1% | at low | -337.8% | at low |
MoonLake Immunotherapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$143.09 M(+164.4%) | -$49.58 M(+15.0%) | -$143.09 M(+31.8%) |
| Sep 2024 | - | -$43.11 M(+41.0%) | -$108.54 M(+38.4%) |
| Jun 2024 | - | -$30.58 M(+54.3%) | -$78.40 M(+28.5%) |
| Mar 2024 | - | -$19.82 M(+31.9%) | -$61.01 M(+12.7%) |
| Dec 2023 | -$54.12 M | -$15.03 M(+15.8%) | -$54.12 M(-3.0%) |
| Sep 2023 | - | -$12.98 M(-1.6%) | -$55.79 M(-3.1%) |
| Jun 2023 | - | -$13.19 M(+2.0%) | -$57.58 M(-7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$12.93 M(-22.5%) | -$62.05 M(-4.6%) |
| Dec 2022 | -$65.06 M | -$16.70 M(+13.0%) | -$65.06 M(+34.5%) |
| Sep 2022 | - | -$14.77 M(-16.3%) | -$48.37 M(+21.3%) |
| Jun 2022 | - | -$17.65 M(+10.7%) | -$39.86 M(-27.4%) |
| Mar 2022 | - | -$15.94 M(+154.4%) | -$54.89 M(+40.9%) |
| Sep 2021 | - | -$6.27 M(-80.8%) | -$38.95 M(+19.2%) |
| Jun 2021 | - | -$32.68 M | -$32.68 M |
FAQ
- What is MoonLake Immunotherapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual EBIT year-on-year change?
- What is MoonLake Immunotherapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly EBIT year-on-year change?
- What is MoonLake Immunotherapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM EBIT year-on-year change?
What is MoonLake Immunotherapeutics annual earnings before interest & taxes?
The current annual EBIT of MLTX is -$143.09 M
What is the all time high annual EBIT for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual earnings before interest & taxes is -$54.12 M
What is MoonLake Immunotherapeutics annual EBIT year-on-year change?
Over the past year, MLTX annual earnings before interest & taxes has changed by -$88.97 M (-164.38%)
What is MoonLake Immunotherapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of MLTX is -$49.58 M
What is the all time high quarterly EBIT for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly earnings before interest & taxes is -$6.27 M
What is MoonLake Immunotherapeutics quarterly EBIT year-on-year change?
Over the past year, MLTX quarterly earnings before interest & taxes has changed by -$6.47 M (-15.00%)
What is MoonLake Immunotherapeutics TTM earnings before interest & taxes?
The current TTM EBIT of MLTX is -$143.09 M
What is the all time high TTM EBIT for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM earnings before interest & taxes is -$32.68 M
What is MoonLake Immunotherapeutics TTM EBIT year-on-year change?
Over the past year, MLTX TTM earnings before interest & taxes has changed by -$34.55 M (-31.83%)